Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Science Translational Medicine · 27.09.2023 · 15 (715)
DOI: 10.1126/scitranslmed.ade3157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 27.09.2023. Verfasst von Meghan Mooring und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIBIB NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Obesity is increasing worldwide and leads to a multitude of metabolic diseases, including cardiovascular disease, type 2 diabetes, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis (NASH). Cysteine-rich angiogenic inducer 61 (CYR61) is associated with the progression of NASH, but it has been described to have anti- and proinflammatory properties. We sought to examine the role of liver CYR61 in NASH progression. CYR61 liver-specific knockout mice on a NASH diet showed improved glucose tolerance, decreased liver inflammation, and reduced fibrosis. CYR61 polarized infiltrating monocytes promoting a proinflammatory/profibrotic phenotype through an IRAK4/SYK/NF-κB signaling cascade. In vitro, CYR61 activated a profibrotic program, including PDGFa/PDGFb expression in macrophages, in an IRAK4/SYK/NF-κB–dependent manner. Furthermore, targeted-antibody blockade reduced CYR61-driven signaling in macrophages in vitro and in vivo, reducing fibrotic development. This study demonstrates that CYR61 is a key driver of liver inflammation and fibrosis in NASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Yale School of Medicine, New Haven, CT 06514, USA.
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06514, USA.
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Pittsburgh Liver Research Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
- Kadmon Corporation LLC, 450 East 29th Street, New York, NY 10016, USA.
ORCID-Profile: Meghan Mooring, Grace A Yeung, Panu Luukkonen, Silvia Liu, Oluwashanu Balogun, Xuemei Yu, Rigen Mo, Masha V Poyurovsky, Carmen J Booth, Liza Konnikova, Gerald I Shulman, Dean Yimlamai
Förderung
- NCATS NIH HHS
- NIBIB NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
Zitieren
APA
Mooring, M., Yeung, G. A., Luukkonen, P., Liu, S., Akbar, M. W., Zhang, G. J., Balogun, O., Yu, X., Mo, R., Nejak-Bowen, K., Poyurovsky, M. V., Booth, C. J., Konnikova, L., Shulman, G. I., & Yimlamai, D. (2023). Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis. Science Translational Medicine, 15(715). https://doi.org/10.1126/scitranslmed.ade3157
Vancouver
Mooring M, Yeung GA, Luukkonen P, Liu S, Akbar MW, Zhang GJ, et al. Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis. Science Translational Medicine. 2023;15(715). doi:10.1126/scitranslmed.ade3157
BibTeX
@article{Mooring2023,
author = {Mooring, Meghan and Yeung, Grace A and Luukkonen, Panu and Liu, Silvia and Akbar, Muhammad Waqas and Zhang, Gary J and Balogun, Oluwashanu and Yu, Xuemei and Mo, Rigen and Nejak-Bowen, Kari and Poyurovsky, Masha V and Booth, Carmen J and Konnikova, Liza and Shulman, Gerald I and Yimlamai, Dean},
title = {Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis},
journal = {Science Translational Medicine},
year = {2023},
volume = {15},
number = {715},
doi = {10.1126/scitranslmed.ade3157}
}
EUVIMED